Corpus ID: 10932321

Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.

@article{Becker1999FecalEO,
  title={Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.},
  author={K. Becker and C. Niederau and T. Frieling},
  journal={Zeitschrift fur Gastroenterologie},
  year={1999},
  volume={37 7},
  pages={
          597-605
        }
}
  • K. Becker, C. Niederau, T. Frieling
  • Published 1999
  • Medicine
  • Zeitschrift fur Gastroenterologie
  • BACKGROUND Quantification of fecal alpha 1-antitrypsin (AAT) excretion is established for estimation of enteric protein loss and assessment of disease activity in inflammatory bowel disease (IBD). In contrast, little is known about prevalence, course, and clinical significance of intestinal leakage of larger-size serum antiproteinases in these disorders. SUBJECTS AND METHODS Firstly, 23 IBD patients (Crohn's disease, CD, n = 17, and ulcerative colitis, UC, n = 6) were examined at 34… CONTINUE READING
    20 Citations
    Enzymes in feces: useful markers of chronic inflammatory bowel disease.
    • 100
    • PDF
    Novel new noninvasive biomarkers of inflammatory bowel disease.
    • S. Kapoor
    • Medicine
    • Inflammatory bowel diseases
    • 2008
    Colorectal Inflammation is Well Predicted by Fecal Calprotectin in Children with Gastrointestinal Symptoms
    • 157
    The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.
    • J. Lewis
    • Biology, Medicine
    • Gastroenterology
    • 2011
    • 349
    • PDF
    Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update
    • 24
    • Highly Influenced
    • PDF
    Clinical significance of inflammatory markers
    • 6
    Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.
    • 10